6841.TWO · EFAI
Taiwan · RS rating 30 · As of 2026-10-08
| Price | 56.70 TWD |
|---|---|
| 1-day change | +1.6% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 73 / 22 / 19 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 16 / 20 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -150.0% |
| Sales growth Q/Q | +40.7% |
| Distance from 52-week high | +31.5% |
| Market cap (USD) | $167.1M |